Sydnexis Secures $45 Million Series B Financing Led By Visionary Ventures And Blue Stem Capital
Amount Raised
$45 Million
Round Type
Series B
Del MarBiotechnologyHealthcareHealth CareScience And EngineeringDescription
Sydnexis, Inc., a clinical stage biopharmaceutical company with a proprietary formulation of low dose atropine for the treatment of progressive myopia, today announced the completion of a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund, with participation from existing investors RA Capital Management, Longitude Capital, and Medicxi. The financing will be used to fund Sydnexis’ lead candidate, SYD-101, through completion of the fully enrolled pivotal Phase 3 STAAR study for the treatment of progressive myopia in children.
Quick answer
Sydnexis raised $45 Million in a Series B round, dated August 10, 2021. Sydnexis is based in Del Mar, California, United States.
- How much did Sydnexis raise?
- Sydnexis raised $45 Million in a Series B round on August 10, 2021.
- What does Sydnexis do?
- Sydnexis is a San Diego based clinical stage pharmaceutical company currently in the middle of a pivotal Phase 3 study, focused on the development of a novel proprietary formulation of low dose atropine for the..
- Where is Sydnexis based and how big is it?
- Sydnexis is based in Del Mar, California, United States. Fundz records about 18 employees.
- Who are the decision-makers at Sydnexis?
- Fundz holds 1 contact at Sydnexis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Science And Engineering around the same time
Companies in the same sectors as Sydnexis that raised within 45 days of this round, from Fundz verified event records.
- Garuda Therapeutics raised $48M on September 24, 2021.
- Garuda Therapeutics raised $72M (Series A) on September 23, 2021.
- Journey Medical Corporation raised $19M on September 22, 2021.
- Iaso Bio raised $108M (Series C) on September 16, 2021.
- CytoDyn raised $2.9M (Seed) on September 16, 2021.
- Walking Fish Therapeutics raised $29M on September 14, 2021.
Who to call at Sydnexis, and when
A new round usually means Sydnexis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sydnexis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sydnexis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sydnexis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sydnexis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSydnexis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.